Overexpression of JMJD6 relates to tumor malignant potential and outcomes of gastric carcinoma.

被引：0

作者：

Ishida, Ryo ^{[1
]}

Komatsu, Shuhei ^{[1
]}

Prefectural, Kyoto ^{[1
]}

Arakawa, Hiroshi ^{[1
]}

Nishibeppu, Keiji ^{[1
]}

Kiuchi, Jun ^{[1
]}

Imamura, Taisuke ^{[1
]}

Ohashi, Takuma ^{[1
]}

Konishi, Hirotaka ^{[1
]}

Shiozaki, Atsushi ^{[1
]}

Kubota, Takeshi ^{[1
]}

Fujiwara, Hitoshi ^{[1
]}

Tsuda, Hitoshi ^{[2
]}

Otsuji, Eigo ^{[1
]}

机构：

[1] Kyoto Prefectural Univ Med, Div Digest Surg, Kyoto, Japan

[2] Natl Def Med Coll Hosp, Dept Pathol, Saitama, Japan

来源：

CANCER SCIENCE | 2025年 / 116卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

J-2028

引用

页码：694 / 694

页数：1

共 50 条

[21] JMJD6 functions as an oncogene and is associated with poor prognosis in esophageal squamous cell carcinoma
Honggang Liu
Menglong Jiang
Fenghui Ma
Jiapei Qin
Xin Zhou
Liqun Xu
Xiaolong Yan
Tao Jiang
BMC Cancer, 23
[22] JMJD6 functions as an oncogene and is associated with poor prognosis in esophageal squamous cell carcinoma
Liu, Honggang
Jiang, Menglong
Ma, Fenghui
Qin, Jiapei
Zhou, Xin
Xu, Liqun
Yan, Xiaolong
Jiang, Tao
BMC CANCER, 2023, 23 (01)
[23] Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer
Zheng, Heng
Tie, Yan
Fang, Zhen
Wu, Xiaoai
Yi, Tao
Huang, Shuang
Liang, Xiao
Qian, Yanping
Wang, Xi
Pi, Ruyu
Chen, Siyuan
Peng, Yong
Yang, Shengyong
Zhao, Xia
Wei, Xiawei
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4
[24] Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer
Heng Zheng
Yan Tie
Zhen Fang
Xiaoai Wu
Tao Yi
Shuang Huang
Xiao Liang
Yanping Qian
Xi Wang
Ruyu Pi
Siyuan Chen
Yong Peng
Shengyong Yang
Xia Zhao
Xiawei Wei
Signal Transduction and Targeted Therapy, 4
[25] Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma
Komatsu, Shuhei
Imoto, Issei
Tsuda, Hitoshi
Kozaki, Ken-ich
Muramatsu, Tomoki
Shimada, Yutaka
Aiko, Satoshi
Yoshizumi, Yutaka
Ichikawa, Daisuke
Otsuji, Eigo
Inazawa, Johji
CARCINOGENESIS, 2009, 30 (07) : 1139 - 1146
[26] LncRNA ZFPM2-AS1 aggravates the malignant development of breast cancer via upregulating JMJD6
Zhao, Y-F
Li, L.
Li, H-J
Yang, F-R
Liu, Z-K
Hu, X-W
Wang, Q.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (21) : 11139 - 11147
[27] Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer
Takashima, Yusuke
Komatsu, Shuhei
Ohashi, Takuma
Kiuchi, Jun
Kamiya, Hajime
Shimizu, Hiroki
Arita, Tomohiro
Konishi, Hirotaka
Shiozaki, Atsushi
Kubota, Takeshi
Okamoto, Kazuma
Fujiwara, Hitoshi
Tsuda, Hitoshi
Otsuji, Eigo
CANCER SCIENCE, 2022, 113 (06) : 1984 - 1998
[28] Predictive network analysis identifies JMJD6 and other potential key drivers in Alzheimer's disease
Merchant, Julie P.
Zhu, Kuixi
Henrion, Marc Y. R.
Zaidi, Syed S. A.
Lau, Branden
Moein, Sara
Alamprese, Melissa L.
Pearse II, Richard V.
Bennett, David A.
Ertekin-Taner, Niluefer
Young-Pearse, Tracy L.
Chang, Rui
COMMUNICATIONS BIOLOGY, 2023, 6 (01)
[29] Predictive network analysis identifies JMJD6 and other potential key drivers in Alzheimer’s disease
Julie P. Merchant
Kuixi Zhu
Marc Y. R. Henrion
Syed S. A. Zaidi
Branden Lau
Sara Moein
Melissa L. Alamprese
Richard V. Pearse
David A. Bennett
Nilüfer Ertekin-Taner
Tracy L. Young-Pearse
Rui Chang
Communications Biology, 6
[30] Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma
Zhang, Chuanjie
Lu, Xuan
Huang, Jingyi
He, Hongchao
Chen, Li
Liu, Yihan
Wang, Haofei
Xu, Yang
Xing, Siwei
Ruan, Xiaohao
Yang, Xiaoqun
Chen, Lu
Xu, Danfeng
CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (02):

← 1 2 3 4 5 →